title: Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone.
abstract: The purpose of the present study was to design a novel carrier system based on a mucoadhesive polymer exhibiting improved properties concerning drug delivery to the vaginal mucosa. This was reached by the covalent attachment of L-cysteine to commercially available polyacrylic acid (Carbopol 974P). Mediated by a carbodiimide, increasing amounts of L-cysteine were covalently linked to the polymer. The resulting thiolated polyacrylic acid conjugates (NaC974P-Cys) displayed between 24.8 and 45.8 micromol thiol groups per gram of polymer. Because of the formation of intra- and/or intermolecular disulfide bonds, the viscosity of an aqueous thiolated polymer gel (3%) increased about 50% at pH 7.0 within 1 h. In oscillatory rheological measurements, it was shown that this increase in viscosity is mainly due to the increase in elasticity. Tensile studies carried out on freshly excised cow vagina demonstrated a significant (P<0.05) increase in the total work of adhesion (TWA) compared to the unmodified polymer. An amount of 24.8 micromol thiol groups per gram of polymer resulted in a 1.45-fold increase in the TWA, whereas an amount of 45.8 micromol showed an even 2.28-fold increase. These improved mucoadhesive properties can be explained by the formation of disulfide bonds between the thiolated polymer and cysteine rich subdomaines of the mucus layer. The release rate of the model drug progesterone from tablets based on microcrystalline cellulose serving as the reference was approximately 1% per hour, whereas it was 0.58% per hour for the unmodified polymer (NaC974P) and 0.12% per hour for the thiolated polymer (NaC974P-Cys). Therefore, this thiolated polymer is a promising carrier for progesterone providing a prolonged residence time and a controlled drug release.
authors.affiliation: Institute of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstrasse 14, A-1090, Vienna, Austria. claudia.valeneta@univie.ac.at
authors.forename: C
authors.initials: C
authors.lastname: Valenta
authors.forename: C E
authors.initials: CE
authors.lastname: Kast
authors.forename: I
authors.initials: I
authors.lastname: Harich
authors.forename: A
authors.initials: A
authors.lastname: Bernkop-Schnürch
mesh_terms: D000179:Acrylates / Q000493:pharmacokinetics; D000269:Adhesives / Q000493:pharmacokinetics*; D000818:Animals; D002417:Cattle; D003545:Cysteine / Q000493:pharmacokinetics; D004337:Drug Carriers / Q000493:pharmacokinetics; D016503:Drug Delivery Systems / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005260:Female; D009092:Mucous Membrane / Q000378:metabolism; D011108:Polymers / Q000493:pharmacokinetics; D011374:Progesterone / Q000493:pharmacokinetics*; D014621:Vagina / Q000378:metabolism*
chemical_list: D000179:Acrylates; D000269:Adhesives; D004337:Drug Carriers; D011108:Polymers; C117167:carbopol 974P NF; D011374:Progesterone; D003545:Cysteine